Herbal hope: new pill aims to stop second strokes in brain bleed survivors
NCT ID NCT07200921
First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 26 times
Summary
This study tests whether Naoxuekang Dropping Pills, a Chinese herbal medicine, can reduce the risk of future strokes, heart attacks, or blood clots in people who recently had a brain bleed caused by high blood pressure. About 1,950 adults will receive either the herbal pill or a placebo for 90 days, alongside standard care. Researchers will track their health for one year to see if the treatment lowers the chance of another vascular event.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBRAL SMALL VESSEL DISEASES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, 100070, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.